reference/1277209

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1277209

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1098-6596 0066-4804
issueIdentifier	5
publicationName	Antimicrobial Agents and Chemotherapy
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8eab07e63c50e2970d3430b6c8f4000f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6f5fe6a992fc844d7884d79b5399c5f1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1f4d50fb83c60b0694226c443d70b0e6
bibliographicCitation	Xu J, Li SY, Almeida DV, Tasneen R, Barnes-Boyle K, Converse PJ, Upton AM, Mdluli K, Fotouhi N, Nuermberger EL. Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis. Antimicrob Agents Chemother. 2019 May;63(5). PMID: 30833432; PMCID: PMC6496099.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6100-0547 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60d77e006c0d0401014437a5f8c08710 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0da43555b5c7420618e4ba30ebe8e217 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5028aca23ca6778909fadf0c97f4f73a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d5995d2869bc4a382b3440ab8796f02 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d13ced986e0eb7e15dc94790c9e3d864 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_704634ae0119e35b3964a36953c006f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8093f99f0dd05bd0d3dc22bdebf97cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e9ea024387641911e3566cdb21e78cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f78619132f05ba876de40742506beff4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1377bec41efe6245d49989f661c1aae3
date	201905
identifier	https://doi.org/10.1128/aac.00021-19 https://pubmed.ncbi.nlm.nih.gov/PMC6496099 https://pubmed.ncbi.nlm.nih.gov/30833432
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/686 https://portal.issn.org/resource/ISSN/0066-4804 https://portal.issn.org/resource/ISSN/1098-6596
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
discusses	http://id.nlm.nih.gov/mesh/M0018224 http://id.nlm.nih.gov/mesh/M0001515 http://id.nlm.nih.gov/mesh/M0492968 http://id.nlm.nih.gov/mesh/M0014907 http://id.nlm.nih.gov/mesh/M0582947 http://id.nlm.nih.gov/mesh/M0273433 http://id.nlm.nih.gov/mesh/M0257529 http://id.nlm.nih.gov/mesh/M0366096 http://id.nlm.nih.gov/mesh/M0019175
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_efdbbf9d9f20cdf89f19d5cc9171b33b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456199 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441401 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388906 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152946

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID175426953

Total number of triples: 52.